( 09939.hk)
市盈率-0.47市净率1.14市销率11.44股息率0.00%上市时间2020-05-22股价1.07港币 (-0.93% , 96.38万港币) 市值4.79亿港币总股本4.47亿上市至今年化投资收益率-48.92%
所属三级行业药品 (恒生) 市盈率17.01市净率1.41市销率1.10股息率3.12%
所属指数指数纳入纳出
备注 (1): 双击编辑备注
发表讨论

开拓药业-B(09939) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1陸群Executive Director2023-04-14--
2倪翔Executive Director2023-04-14--
3劉澄偉Non Executive Director2022-05-05--
4盧燕Executive Director2022-01-312023-04-13
5衛舸琪Non Executive Director2021-09-27--
6高維鵬Non Executive Director2021-06-22--
7王衍Non Executive Director2021-04-302022-05-05
8童亮Independent Non Executive Director2020-10-27--
9吳亞玲Non Executive Director2020-10-272021-09-27
10張偉Non Executive Director2020-07-172021-11-26
11XU Min MichaelIndependent Non Executive Director2019-08-12--
12楊懷嚴Independent Non Executive Director - A/F2019-08-12--
13陸剛Non Executive Director2019-08-122022-01-31
14陳傑Non Executive Director2019-08-122021-06-22
15陳兵Non Executive Director2019-08-122021-04-30
16郭創新Non Executive Director2019-08-122020-12-28
17JIN Fen Yu JohnIndependent Non Executive Director2019-08-122020-12-28
18陳曉艷Non Executive Director2019-08-122020-07-17
19TONG You ZhiExecutive DirectorChairman, CEO2018-05-16--